ABSTRACT
OBJECTIVE To examine whether the age distribution of COVID-19 deaths and the share of deaths in nursing homes changed in the second versus the first pandemic wave.
ELIGIBLE DATA We considered all countries that had at least 4000 COVID-19 deaths occurring as of November 25, 2020, at least 200 COVID-19 deaths occurring in the first wave period, and at least 200 COVID-19 deaths occurring in the second wave period; and which had sufficiently detailed information available on the age distribution of these deaths. We also considered countries with data available on COVID-19 deaths of nursing home residents for the two waves.
MAIN OUTCOME MEASURES Change in the second wave versus the first wave in the proportion of COVID-19 deaths occurring in people <50 years old among all COVID-19 deaths and among COVID019 deaths in people <70 years old; and change in the proportion of COVID-19 deaths in nursing home residents among all COVID-19 deaths.
RESULTS Data on age distribution in eligible locations were available for 11 countries. Individuals <50 years old tended to have a larger share in the total COVID-19 deaths in the second wave than in the first wave in western European countries and the USA, but the absolute difference did not exceed 0.5% in any country. The proportion of deaths in individuals <50 years old was higher in Turkey and Ukraine, but it decreased in the second wave. Separate data on nursing home COVID-19 deaths for first and second waves were available for 9 countries. With the exception of Australia, the share of COVID-19 deaths that were accounted by nursing home residents decreased in the second wave, and the decrease was significant and substantial (relative risk estimates: 0.28 to 0.78) in 7/9 countries.
CONCLUSIONS In the examined countries, age distribution of COVID-19 deaths has been fairly similar in the second versus the first wave, but the contribution of COVID-19 deaths in nursing home residents to total fatalities has decreased in most countries in the second wave.
What is known on this topic * COVID-19 risk of death has a very steep age gradient
* Many COVID-19 deaths occur in nursing home residents
* Many countries have seen a pattern of two separate waves of COVID-19, but it is unknown whether these two waves differ in the age distribution of COVID-19 deaths and in fatalities in nursing home residents
What this study adds * Age distribution of COVID-19 deaths has been fairly similar in the second versus the first wave in most countries, with some exceptions.
* Deaths in people <50 years old remain a small minority of COVID-19 deaths.
* The contribution of deaths in nursing home residents to total fatalities remains high in absolute magnitude, but it has decreased in most countries in the second wave.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
METRICS is supported by grants by the Laura and John Arnold Foundation. CA is supported by postdoctoral grants from Uppsala University, the Swedish Society of Medicine, the Blanceflor Foundation, and the Sweden-America Foundation. The authors had no financial relationships with any organisations that might have an interest in the submitted work in the previous three years, and no other relationships or activities that could appear to have influenced the submitted work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Not applicable to this type of study.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All the data are in the manuscript and tables.
